News

Quadric Secures $30M to Advance Innovative AI Inference Chips

Quadric Secures $30M to Advance Innovative AI Inference Chips

Quadric Secures $30M to Drive AI Inference Chip Innovations

Quadric, a trailblazer in the on-device AI chip market, has made headlines by raising an impressive $30 million in their recent Series C funding round. This funding round, which surpassed expectations, has increased the total capital raised by the company to an exciting $72 million, signaling robust investor confidence in its innovative vision.

The funding is spearheaded by the ACCELERATE Fund, managed by BEENEXT Capital Management, with noteworthy participation from Uncork Capital, which brought additional insider support, and was joined by new investors such as Volta, Gentree, Wanxiang America, Pivotal, and Silicon Catalyst Ventures.

Significant Revenue Growth and Market Positioning

As Quadric enters the new year, they are optimistic about their growth trajectory. The recent funding comes at a time when the company has reported exceptional progress, with product revenues tripling compared to previous years. Their strategic plans for 2026 are buoyed by increasing design wins, thanks to the rapid adoption of their General Purpose NPU (GPNPU) processor IP across various industries including edge LLM, automotive, and enterprise vision applications.

Hero Choudhary, Managing Partner at BEENEXT, expressed notable confidence in Quadric, pointing to its notable architecture and innovative approach to AI inference at the edge. He indicates the potential for Quadric to revolutionize the hardware sector of edge AI, demonstrating a promising future ahead.

Innovative Architecture Tailored for Future Success

Quadric's offerings enable the development of highly capable AI inference chips that can adhere to the dynamic nature of AI model development. The legacy technologies currently in use often fall short of expectations, unable to adapt when it comes to new AI models. This poses a risk to developers who invest in architectures that are unable to evolve over time.

The Chimera™ processor IP from Quadric is purposefully crafted to eliminate such vulnerabilities. Unlike fixed-function NPUs, Chimera is a fully programmable platform capable of executing any AI model, irrespective of its specifications. This feature ensures that developers can safeguard their investments against the rapid evolution of AI in technology.

This highly effective processor allows developers to deploy computer vision and LLM applications while accommodating models with up to 30 billion parameters. As a result, customers benefit from exceptional performance per watt, allowing for quicker transitions from initial engagement to readiness for production in under six months.

Scalable Performance Across Applications

The scalability of Chimera GPNPU cores, ranging from 1 tera operations per second (TOPS) to an impressive 864 TOPS, provides flexibility for both commercial and automotive safety-enhanced configurations. This versatility makes Quadric a leading choice in sectors where performance and reliability are paramount.

Evident Market Traction and Growth Potential

Jeff Clavier, Founding Partner at Uncork Capital, lauded Quadric’s unique achievement in product revenue, attributing this progress to authentic customer adoption rather than mere speculation. He highlighted the growing software ecosystem that is forming around the Chimera platform, asserting that it has the potential to become a defining feature in the industry.

Recently, Quadric has expanded its roster of licensees, extending its influence across automotive applications, office automation, edge LLM, and autonomous driving developments. Alongside this funding news, they announced two exciting license agreements, one with a potential edge-server LLM silicon provider and the other with Tier IV from Japan, recognized for its innovations in self-driving technologies.

Commitment to Customer-Focused Growth

Veerbhan Kheterpal, CEO and co-founder of Quadric, emphasized the company’s mission: to deliver the best AI inference chips that combine outstanding performance with robust software solutions. The recent infusion of growth capital is strategically allocated to strengthen teams and technologies that support customer success, ensuring that clients can navigate the challenges posed by ongoing shifts in AI models confidently.

About Quadric

Headquartered in Burlingame, California, Quadric serves as the driving force behind on-device AI chips. Their widely trusted General Purpose NPU (GPNPU) processor IP and comprehensive toolchain enables clients to transition from concept to production-grade AI silicon within a remarkably short timeframe. With additional capabilities tailored for automotive industries and a knack for scaling to 864 TOPS, Quadric stands at the forefront of AI technology evolution.

Learn more about Quadric and their innovative solutions at https://quadric.ai.

Frequently Asked Questions

What is Quadric's recent funding achievement?

Quadric recently announced a successful oversubscribed Series C funding round, raising $30 million, increasing total capital to $72 million.

What sectors does Quadric's technology serve?

Quadric’s technology extends to edge LLM, automotive, office automation, and autonomous driving applications, showcasing its versatility.

What distinguishes the Chimera processor IP?

Chimera is fully programmable, allowing it to run any AI model, thus future-proofing investments against rapid architectural shifts in AI.

Who are some of Quadric's investors?

Notable investors in this recent funding include BEENEXT Capital Management, Uncork Capital, Volta, Gentree, Wanxiang America, Pivotal, and Silicon Catalyst Ventures.

What is Quadric's commitment moving forward?

Quadric is focused on delivering top-tier AI inference chips with advanced software solutions, leveraging growth capital to enhance customer success.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 9

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 17

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 15

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 7

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 7

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 9

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 12

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Upcoming Earnings Announcements and Market Insights

Updated Category News Views 249

Companies Reporting Earnings Before The Market Opens Various companies are preparing for their quarterly earnings reports, each with expectations that could impact their stock performance in the market. For example, Bank of Hawaii is anticipated to report quarterly earnings of $1.05 per share on revenue of approximately $174.39 million. Similarly, Business First...

Continue Reading
Bloom Nutrition Unveils Bloom Pop: A Healthier Soda Choice

Updated Category News Views 425

Bloom Nutrition Introduces Bloom Pop Bloom Nutrition, the brand known for revolutionizing the wellness industry, has launched an exciting new product called Bloom Pop. This innovative soda is now available exclusively at Walmart, marking a significant step in the brand's journey towards making healthier options fun and accessible. A Bold and Bubbly Innovation Bloom Pop...

Continue Reading
Renault Surpasses Stellantis in European Car Market Growth

Updated Category News Views 502

Renault's Growth in the European Car Market Recent statistics reveal that new car sales in Europe showed a modest increase of 0.9% in 2024, primarily driven by a significant rise in hybrid vehicle registrations. This surge marks the fourth consecutive month where hybrid sales have surpassed those of petrol vehicles, indicating a pivotal shift in consumer preferences....

Continue Reading
Market Reactions Following Intense Presidential Debate Showdown

Updated Category News Views 91

Markets React to the Presidential Debate U.S. stock futures slipped and the dollar softened as investors watched a heated presidential debate reshape the political conversation. It was the first direct face-off between Republican candidate Donald Trump and Democratic Vice President Kamala Harris. Early reads from traders and analysts suggested Harris may have had the...

Continue Reading
Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in UK

Updated Category News Views 81

Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in the UK Eli Lilly and Company has recently celebrated a significant milestone with the approval of their innovative treatment, Kisunla™ (donanemab-azbt), for mild cognitive impairment and mild dementia associated with Alzheimer's disease. This groundbreaking therapy is specifically designed for adult...

Continue Reading